Kelly, Jared Ryan

Insider profile

Performance

Overall performance

Performance over holding periods
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Kelly, Jared Ryan's trades of Oncolytics Biotech Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-13 2026-03-12 B Purchase
87,692 -19.5%
39.78
US$4,001,854
87,692 -19.5% 39.78 US$4,001,854
2026-02-13 2026-02-12 B Purchase
55,208 -40.3%
17.34
US$4,894,943
55,208 -40.3% 17.34 US$4,894,943
2026-02-13 2026-02-11 B Purchase
94,540 +31.3%
259.26
US$1,011,155
94,540 +31.3% 259.26 US$1,011,155
2025-08-12 2025-08-12 B Purchase
23,500 +46.6%
0.86
US$20,280
23,500 +46.6% 0.86 US$20,280
2025-07-17 2025-07-16 B Purchase
50,400
1.19
US$60,062
50,400 1.19 US$60,062